临床实践指南中去强化治疗建议的研究：是加强还是减少？
An Examination of Deintensification Recommendations in Clinical Practice Guidelines: Stepping Up or Scaling Back?
机构信息
VA Center for Clinical Management and Research, Ann Arbor, Michigan.
University of Michigan Medical School, Ann Arbor, Michigan.
出版信息
JAMA Intern Med. 2018 Mar 1;178(3):414-416. doi: 10.1001/jamainternmed.2017.7198.
Abstract
In light of initiatives to decrease use of unnecessary services, this article examines whether current guidelines for diabetes and cardiovascular disease preferentially recommend intensification rather than deintensification of care.
摘要
鉴于减少不必要服务使用的举措，本文探讨了当前关于糖尿病和心血管疾病的指南是否优先推荐强化而非弱化治疗。
相似文献
1
An Examination of Deintensification Recommendations in Clinical Practice Guidelines: Stepping Up or Scaling Back?
JAMA Intern Med. 2018 Mar 1;178(3):414-416. doi: 10.1001/jamainternmed.2017.7198.
2
Orthopaedic Healthcare Worldwide: Using Clinical Practice Guidelines in Clinical Decision Making.
Clin Orthop Relat Res. 2015 Sep;473(9):2762-4. doi: 10.1007/s11999-015-4336-4. Epub 2015 May 16.
3
Consensus and clinical practice guidelines in Latin America: Who, where, when and how.
Ann Hepatol. 2019 Mar-Apr;18(2):281-284. doi: 10.1016/j.aohep.2019.03.001. Epub 2019 Apr 15.
4
Physician adherence to clinical practice guidelines: does it really matter?
Am Heart J. 2003 Jan;145(1):13-5. doi: 10.1067/mhj.2003.25.
5
Changing Current Practice in Urology: Improving Guideline Development and Implementation Through Stakeholder Engagement.
Eur Urol. 2017 Aug;72(2):161-163. doi: 10.1016/j.eururo.2017.02.008. Epub 2017 Feb 22.
6
Clinical inertia-Time to reappraise the terminology?
Prim Care Diabetes. 2017 Apr;11(2):105-106. doi: 10.1016/j.pcd.2017.01.007. Epub 2017 Feb 20.
7
Is it time to change follow-up recommendations in colorectal cancer?
Clin Transl Oncol. 2020 Jan;22(1):163-164. doi: 10.1007/s12094-019-02117-8. Epub 2019 May 10.
8
Cardiovascular events, diabetes and guidelines: the virtue of simplicity.
Cardiovasc Diabetol. 2019 Mar 28;18(1):42. doi: 10.1186/s12933-019-0844-y.
9
The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial Components.
Tex Heart Inst J. 2016 Aug 1;43(4):313-4. doi: 10.14503/THIJ-16-5798. eCollection 2016 Aug.
10
Equity of access to kidney transplantation: to what extent should international guidelines differ?
Transplantation. 2012 Oct 15;94(7):669-70. doi: 10.1097/TP.0b013e31826370ab.
引用本文的文献
1
BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes.
Endocrine. 2024 Feb;83(2):399-404. doi: 10.1007/s12020-023-03547-9. Epub 2023 Oct 3.
2
Focus and features of prescribing indications spanning multiple chronic conditions in older adults: A narrative review.
J Multimorb Comorb. 2021 Apr 28;11:26335565211012876. doi: 10.1177/26335565211012876. eCollection 2021 Jan-Dec.
3
Expert Panel Guidance and Narrative Review of Treatment Simplification of Complex Insulin Regimens to Improve Outcomes in Type 2 Diabetes.
Diabetes Ther. 2022 Apr;13(4):619-634. doi: 10.1007/s13300-022-01222-2. Epub 2022 Mar 11.
4
[The problem of medical overuse : Finding a definition and solutions].
Internist (Berl). 2021 Apr;62(4):343-353. doi: 10.1007/s00108-021-00957-7. Epub 2021 Feb 13.
5
Potential diabetes overtreatment and risk of adverse events among older adults in Ontario: a population-based study.
Diabetologia. 2021 May;64(5):1093-1102. doi: 10.1007/s00125-020-05370-7. Epub 2021 Jan 25.
6
GP's perspectives on laboratory test use for monitoring long-term conditions: an audit of current testing practice.
BMC Fam Pract. 2020 Dec 5;21(1):257. doi: 10.1186/s12875-020-01331-6.
7
Rates, determinants and success of implementing deprescribing in people with type 2 diabetes: A scoping review.
Diabet Med. 2021 Feb;38(2):e14408. doi: 10.1111/dme.14408. Epub 2020 Oct 2.
8
Low-Value Care and Clinician Engagement in a Large Medicare Shared Savings Program ACO: a Survey of Frontline Clinicians.
J Gen Intern Med. 2020 Jan;35(1):133-141. doi: 10.1007/s11606-019-05511-8. Epub 2019 Nov 8.
9
Approaches to Risk Assessment Among Older Patients With Diabetes.
Curr Diab Rep. 2019 Jul 19;19(8):59. doi: 10.1007/s11892-019-1172-z.
10
Clinical practice guidelines for older people with multimorbidity and life-limiting illness: what are the implications for deprescribing?
Ther Adv Drug Saf. 2018 Sep 12;9(11):619-630. doi: 10.1177/2042098618795770. eCollection 2018 Nov.
本文引用的文献
1
Inclusion of Hypoglycemia in Clinical Practice Guidelines and Performance Measures in the Care of Patients With Diabetes.
JAMA Intern Med. 2016 Nov 1;176(11):1714-1716. doi: 10.1001/jamainternmed.2016.5046.
2
Deintensification of Routine Medical Services: The Next Frontier for Improving Care Quality.
JAMA Intern Med. 2016 Jul 1;176(7):978-80. doi: 10.1001/jamainternmed.2016.2292.
3
Undermeasuring Overuse--An Examination of National Clinical Performance Measures.
JAMA Intern Med. 2015 Oct;175(10):1709-11. doi: 10.1001/jamainternmed.2015.4025.
4
Choosing wisely--the politics and economics of labeling low-value services.
N Engl J Med. 2014 Feb 13;370(7):589-92. doi: 10.1056/NEJMp1314965. Epub 2014 Jan 22.
5
Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.
JAMA. 2007 Sep 12;298(10):1209-12. doi: 10.1001/jama.298.10.1209.
Zotero 插件